Archive for September 22nd, 2021

Bolder Surgical announces global launch of the CoolSeal™ Vessel Sealing Platform

CoolSeal receives CE mark, Japan PMDA approval; now available in over 20 countries worldwide LOUISVILLE, COLORADO, Sept. 22, 2021 (GLOBE NEWSWIRE) — Bolder Surgical today announced the global launch of its CoolSeal™ Vessel Sealing platform. CoolSeal has been in use since October 2020 in the U.S., and with the new international regulatory approvals the devices are available in […]
Read More

Bolder Surgical announces global launch of the CoolSeal™ Vessel Sealing Platform

CoolSeal receives CE mark, Japan PMDA approval; now available in over 20 countries worldwide LOUISVILLE, COLORADO, Sept. 22, 2021 (GLOBE NEWSWIRE) — Bolder Surgical today announced the global launch of its CoolSeal™ Vessel Sealing platform. CoolSeal has been in use since October 2020 in the U.S., and with the new international regulatory approvals the devices are available in […]
Read More

Laserfiche Announces Launch of Cloud Document Management and Process Automation Solution to EMEA Region, Supports Digital Resiliency Strategies

LONDON, Sept. 22, 2021 /PRNewswire/ — Laserfiche today announced the availability of Laserfiche Cloud in the Europe, Middle East and Africa (EMEA) region. The leading SaaS provider of intelligent content management and business process automation’s cloud offering delivers an innovative and trusted system for securely managing content and automating business processes across the enterprise. With digital workflows, […]
Read More

Adagio Therapeutics informa sobre o Programa de Anticorpos COVID-19, bem como sobre os Destaques de Negócios e Resultados Financeiros do Segundo Trimestre de 2021

Novos Dados que Corroboram o Potencial do ADG20 para o Tratamento e Prevenção da COVID-19 Serão Divulgados na IDWeek 2021 Número de Pacientes do Ensaio Clínico da Fase 2/3 do EVADE Global de ADG20 Expandido após Avaliação IDMC Conclusão da IPO de US$355,8 milhões para financiar o avanço contínuo do portfólio de soluções com base […]
Read More

Adagio Therapeutics apporte des mises à jour du programme d’anticorps contre la COVID-19, et révèle les récents faits marquants de son activité et les résultats financiers du deuxième trimestre 2021

De nouvelles données étayant le potentiel de l’ADG20 pour le traitement et la prévention de la COVID-19 seront présentées lors de l’IDWeek 2021 La population de patients participant à l’essai clinique mondial EVADE de phase 2/3 de l’ADG20 a été élargie suite à l’évaluation de l’IDMC Une introduction en bourse de 355,8 millions de dollars a […]
Read More

Archives

September 2021
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930